Olympiad Research’s NOV NOV Stock Holding History

Olympiad Research’s Portfolio NOV Stock Details NOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,595	Closed	-$242K	–	392
2023 Q3	$242K	Buy	+11,595	New	+$230K	0.24%	197

Other funds holding NOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Olympiad Research's NOV Position: Q4 2023 in Review

Olympiad Research sold out of NOV (NOV) in Q4 2023, closing a stake of 11,595 shares — an estimated $242K sold.

Olympiad Research first reported a position in NOV in Q3 2023 and held it in 1 quarter. The position peaked at $242K in Q3 2023. 392 funds tracked by Wall St. Rank hold NOV as of Q4 2023.

Olympiad Research reported no remaining NOV position as of Q4 2023 after selling out during the quarter.
Olympiad Research sold 11,595 NOV shares in Q4 2023, an estimated $242K.
Olympiad Research first reported a position in NOV in Q3 2023 and held it in 1 quarter.
Olympiad Research's NOV position peaked at $242K in Q3 2023.
392 funds tracked by Wall St. Rank held NOV as of Q4 2023.

Based on Olympiad Research's 13F filing for Q4 2023, filed 12 Feb 2024.